Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Escalating Doses of CPT-11 and 5fluorouracil (5FU) Plus PN401 With a Fixed Dose of Leucovorin in Patients With Solid Tumor Malignancies.

NCT00044785 is registered in ClinicalTrials.gov with Wellstat Therapeutics as lead sponsor.

NCT NCT00044785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00044785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Escalating Doses of CPT-11 and 5fluorouracil (5FU) Plus PN401 With a Fixed Dose of Leucovorin in Patients With Solid Tumor Malignancies.
Lead sponsor
Wellstat Therapeutics
Phase
Phase 1
Overall status
Terminated
Start date
August 31, 2002
Completion date
March 31, 2004
Enrollment
24
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumors